0001415889-21-002268.txt : 20210504 0001415889-21-002268.hdr.sgml : 20210504 20210504190745 ACCESSION NUMBER: 0001415889-21-002268 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210430 FILED AS OF DATE: 20210504 DATE AS OF CHANGE: 20210504 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Watkin Jared CENTRAL INDEX KEY: 0001645118 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 21890477 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: AP6A-2, D-032L CITY: ABBOTT PARK STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 form4-05042021_040530.xml X0306 4 2021-04-30 0000001800 ABBOTT LABORATORIES ABT 0001645118 Watkin Jared 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 false true false false SENIOR VICE PRESIDENT Common shares without par value 2021-04-30 4 S 0 9533 120.016 D 59783 D Common shares without par value 2021-04-30 4 M 0 17043 44.40 A 76826 D Common shares without par value 2021-04-30 4 M 0 68000 59.94 A 144826 D Common shares without par value 2021-04-30 4 S 0 85043 119.8879 D 59783 D Common shares without par value 602 I Profit Sharing Trust Option (right to buy) 44.40 2021-04-30 4 M 0 17043 0 D 2018-02-17 2027-02-16 Common Shares 17043 0 D Option (right to buy 59.94 2021-04-30 4 M 0 68000 0 D 2019-02-16 2028-02-15 Common Shares 68000 33987 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.0103 to $120.08, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.38 to $120.13, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Balance in the Abbott Laboratories Stock Retirement Trust as of April 30, 2021. Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. /s/ Jared Watkin by Jessica H. Paik, Attorney-in-Fact 2021-05-04